Market Research Report
Commercial Potential of the Forthcoming US Biosimilars Market
|Published by||Frost & Sullivan||Product code||296958|
|Published||Content info||156 Pages
Delivery time: 1-2 business days
|Commercial Potential of the Forthcoming US Biosimilars Market|
|Published: February 21, 2014||Content info: 156 Pages||
An Addendum to "Specialty Physicians Discuss their Opinions of the United States Biosimilars Market"
Frost & Sullivan assessed physicians' willingness to prescribe biosimilars in the United States. The objective of this research was to conduct a highly qualitative analysis of a representative sample of 20 preselected practicing specialty physicians in the United States in the spirit of an interactive roundtable discussion. The primary goal was to encourage participants to freely express opinions and ideas around all aspects of a topic, facilitating a free exchange about how biosimilars will impact their practice and the overall US healthcare market. The biosimilar research panel was conducted over a three-day period (October 11-13, 2011). Questions and discussions were designed to gauge both short-term and long-term trends and impacts.